|
2008
|
Invention
|
Ergoline derivatives as selective radical scavengers for neurons. The present invention relates t... |
|
|
Invention
|
Stabilised aqueous solutions of ergoline compounds. The present invention relates to stabilized a... |
|
2007
|
Invention
|
Transdermal therapeutic system with two-phase release profile.
The present invention relates to ... |
|
|
Invention
|
Transdermal therapeutic system with two-phase releasing profile. The present invention relates to... |
|
2005
|
Invention
|
Transdermal therapeutic system.
Use of a transdermal therapeutic system (TTS) comprising a pharm... |
|
|
Invention
|
Transdermal therapeutic system.
The invention concerns a transdermal therapeutic system containi... |
|
|
Invention
|
Transdermal therapeutic systems. The invention concerns a transdermal therapeutic system containi... |
|
2004
|
Invention
|
Agent containing ergoline for transdermal application.
The invention relates to a transdermal th... |
|
|
Invention
|
Agent containing ergolin for transdermal application. The invention relates to a transdermal, the... |
|
2003
|
Invention
|
Use of a dopamine agonist with a short half-life for treating illnesses which can be treated by d... |
|
|
Invention
|
Transdermal therapeutic system for treating restless-legs-syndrome. The invention relates to the ... |
|
|
Invention
|
Transdermal therapeutic system. Use of a transdermal therapeutic system (TTS) comprising a pharma... |
|
|
Invention
|
Combination of a transdermal therapeutic system and an oral and/or parenteral preparation contain... |
|
2002
|
Invention
|
Methods of using 1-allyl ergot alkaloid derivatives to treat migraines. 2 receptors for the preve... |
|
|
Invention
|
1-allyl ergot alkaloid derivatives, methods for their production and their use for migraine preve... |
|
1993
|
Invention
|
Agent for transdermal administration containing ergoline derivatives. An agent for transdermal ad... |
